nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanabenz—CYP1A2—Carmustine—melanoma	0.21	0.417	CbGbCtD
Guanabenz—CYP1A2—Vemurafenib—melanoma	0.166	0.33	CbGbCtD
Guanabenz—CYP1A2—Dacarbazine—melanoma	0.127	0.253	CbGbCtD
Guanabenz—NISCH—Paclitaxel—Docetaxel—melanoma	0.0114	1	CbGdCrCtD
Guanabenz—Haemorrhage—Bleomycin—melanoma	0.00106	0.00316	CcSEcCtD
Guanabenz—Pulmonary oedema—Docetaxel—melanoma	0.00106	0.00315	CcSEcCtD
Guanabenz—Hyperglycaemia—Carmustine—melanoma	0.00104	0.00311	CcSEcCtD
Guanabenz—Upper respiratory tract infection—Temozolomide—melanoma	0.00104	0.0031	CcSEcCtD
Guanabenz—Weight increased—Temozolomide—melanoma	0.00102	0.00304	CcSEcCtD
Guanabenz—Weight decreased—Temozolomide—melanoma	0.00101	0.00302	CcSEcCtD
Guanabenz—Hyperglycaemia—Temozolomide—melanoma	0.00101	0.00301	CcSEcCtD
Guanabenz—Infestation NOS—Temozolomide—melanoma	0.000998	0.00297	CcSEcCtD
Guanabenz—Infestation—Temozolomide—melanoma	0.000998	0.00297	CcSEcCtD
Guanabenz—Body temperature increased—Vemurafenib—melanoma	0.000984	0.00293	CcSEcCtD
Guanabenz—Chills—Bleomycin—melanoma	0.000953	0.00284	CcSEcCtD
Guanabenz—Erythema multiforme—Dactinomycin—melanoma	0.000936	0.00279	CcSEcCtD
Guanabenz—Haemoglobin—Carmustine—melanoma	0.000931	0.00278	CcSEcCtD
Guanabenz—Haemorrhage—Carmustine—melanoma	0.000927	0.00276	CcSEcCtD
Guanabenz—Erythema—Bleomycin—melanoma	0.000924	0.00275	CcSEcCtD
Guanabenz—Hypersensitivity—Vemurafenib—melanoma	0.000917	0.00273	CcSEcCtD
Guanabenz—Oedema peripheral—Carmustine—melanoma	0.000913	0.00272	CcSEcCtD
Guanabenz—Connective tissue disorder—Carmustine—melanoma	0.000911	0.00271	CcSEcCtD
Guanabenz—Dermatitis bullous—Docetaxel—melanoma	0.000901	0.00268	CcSEcCtD
Guanabenz—Haemoglobin—Temozolomide—melanoma	0.0009	0.00268	CcSEcCtD
Guanabenz—Haemorrhage—Temozolomide—melanoma	0.000895	0.00267	CcSEcCtD
Guanabenz—Asthenia—Vemurafenib—melanoma	0.000893	0.00266	CcSEcCtD
Guanabenz—Chills—Dactinomycin—melanoma	0.000888	0.00265	CcSEcCtD
Guanabenz—Oedema peripheral—Temozolomide—melanoma	0.000882	0.00263	CcSEcCtD
Guanabenz—Cardiac failure—Docetaxel—melanoma	0.000882	0.00263	CcSEcCtD
Guanabenz—Pruritus—Vemurafenib—melanoma	0.000881	0.00263	CcSEcCtD
Guanabenz—Connective tissue disorder—Temozolomide—melanoma	0.00088	0.00262	CcSEcCtD
Guanabenz—Eye disorder—Carmustine—melanoma	0.000866	0.00258	CcSEcCtD
Guanabenz—Hyponatraemia—Docetaxel—melanoma	0.000864	0.00258	CcSEcCtD
Guanabenz—Erythema—Dactinomycin—melanoma	0.000862	0.00257	CcSEcCtD
Guanabenz—Ill-defined disorder—Bleomycin—melanoma	0.000857	0.00256	CcSEcCtD
Guanabenz—Anaemia—Bleomycin—melanoma	0.000854	0.00255	CcSEcCtD
Guanabenz—Diarrhoea—Vemurafenib—melanoma	0.000852	0.00254	CcSEcCtD
Guanabenz—Erythema multiforme—Temozolomide—melanoma	0.000847	0.00252	CcSEcCtD
Guanabenz—Eye disorder—Temozolomide—melanoma	0.000837	0.00249	CcSEcCtD
Guanabenz—Tinnitus—Temozolomide—melanoma	0.000835	0.00249	CcSEcCtD
Guanabenz—Malaise—Bleomycin—melanoma	0.000833	0.00248	CcSEcCtD
Guanabenz—Leukopenia—Bleomycin—melanoma	0.000827	0.00247	CcSEcCtD
Guanabenz—Dizziness—Vemurafenib—melanoma	0.000823	0.00245	CcSEcCtD
Guanabenz—Immune system disorder—Temozolomide—melanoma	0.000809	0.00241	CcSEcCtD
Guanabenz—Mediastinal disorder—Temozolomide—melanoma	0.000807	0.00241	CcSEcCtD
Guanabenz—Erythema—Carmustine—melanoma	0.000807	0.0024	CcSEcCtD
Guanabenz—Malnutrition—Carmustine—melanoma	0.000807	0.0024	CcSEcCtD
Guanabenz—Cough—Bleomycin—melanoma	0.000806	0.0024	CcSEcCtD
Guanabenz—Chills—Temozolomide—melanoma	0.000803	0.0024	CcSEcCtD
Guanabenz—Dehydration—Docetaxel—melanoma	0.000801	0.00239	CcSEcCtD
Guanabenz—Ill-defined disorder—Dactinomycin—melanoma	0.0008	0.00238	CcSEcCtD
Guanabenz—Anaemia—Dactinomycin—melanoma	0.000797	0.00237	CcSEcCtD
Guanabenz—Liver function test abnormal—Docetaxel—melanoma	0.000795	0.00237	CcSEcCtD
Guanabenz—Vomiting—Vemurafenib—melanoma	0.000791	0.00236	CcSEcCtD
Guanabenz—Dry skin—Docetaxel—melanoma	0.000789	0.00235	CcSEcCtD
Guanabenz—Chest pain—Bleomycin—melanoma	0.000787	0.00235	CcSEcCtD
Guanabenz—Myalgia—Bleomycin—melanoma	0.000787	0.00235	CcSEcCtD
Guanabenz—Orthostatic hypotension—Docetaxel—melanoma	0.000786	0.00234	CcSEcCtD
Guanabenz—Rash—Vemurafenib—melanoma	0.000785	0.00234	CcSEcCtD
Guanabenz—Dermatitis—Vemurafenib—melanoma	0.000784	0.00234	CcSEcCtD
Guanabenz—Back pain—Carmustine—melanoma	0.00078	0.00233	CcSEcCtD
Guanabenz—Headache—Vemurafenib—melanoma	0.00078	0.00232	CcSEcCtD
Guanabenz—Erythema—Temozolomide—melanoma	0.00078	0.00232	CcSEcCtD
Guanabenz—Malnutrition—Temozolomide—melanoma	0.00078	0.00232	CcSEcCtD
Guanabenz—Breast disorder—Docetaxel—melanoma	0.000778	0.00232	CcSEcCtD
Guanabenz—Discomfort—Bleomycin—melanoma	0.000777	0.00232	CcSEcCtD
Guanabenz—Malaise—Dactinomycin—melanoma	0.000777	0.00232	CcSEcCtD
Guanabenz—Cramp muscle—Docetaxel—melanoma	0.000775	0.00231	CcSEcCtD
Guanabenz—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000775	0.00231	CcSEcCtD
Guanabenz—Leukopenia—Dactinomycin—melanoma	0.000771	0.0023	CcSEcCtD
Guanabenz—Confusional state—Bleomycin—melanoma	0.00076	0.00227	CcSEcCtD
Guanabenz—Vision blurred—Carmustine—melanoma	0.00076	0.00227	CcSEcCtD
Guanabenz—Oedema—Bleomycin—melanoma	0.000754	0.00225	CcSEcCtD
Guanabenz—Back pain—Temozolomide—melanoma	0.000754	0.00225	CcSEcCtD
Guanabenz—Infection—Bleomycin—melanoma	0.000749	0.00223	CcSEcCtD
Guanabenz—Anaemia—Carmustine—melanoma	0.000746	0.00222	CcSEcCtD
Guanabenz—Agitation—Carmustine—melanoma	0.000741	0.00221	CcSEcCtD
Guanabenz—Nausea—Vemurafenib—melanoma	0.000739	0.0022	CcSEcCtD
Guanabenz—Thrombocytopenia—Bleomycin—melanoma	0.000738	0.0022	CcSEcCtD
Guanabenz—Vision blurred—Temozolomide—melanoma	0.000735	0.00219	CcSEcCtD
Guanabenz—Myalgia—Dactinomycin—melanoma	0.000734	0.00219	CcSEcCtD
Guanabenz—Bronchospasm—Docetaxel—melanoma	0.000732	0.00218	CcSEcCtD
Guanabenz—Discomfort—Dactinomycin—melanoma	0.000725	0.00216	CcSEcCtD
Guanabenz—Ill-defined disorder—Temozolomide—melanoma	0.000723	0.00216	CcSEcCtD
Guanabenz—Leukopenia—Carmustine—melanoma	0.000722	0.00215	CcSEcCtD
Guanabenz—Anaemia—Temozolomide—melanoma	0.00072	0.00215	CcSEcCtD
Guanabenz—Anorexia—Bleomycin—melanoma	0.000719	0.00214	CcSEcCtD
Guanabenz—Agitation—Temozolomide—melanoma	0.000716	0.00214	CcSEcCtD
Guanabenz—Angioedema—Temozolomide—melanoma	0.000712	0.00212	CcSEcCtD
Guanabenz—Hypotension—Bleomycin—melanoma	0.000705	0.0021	CcSEcCtD
Guanabenz—Oedema—Dactinomycin—melanoma	0.000703	0.0021	CcSEcCtD
Guanabenz—Malaise—Temozolomide—melanoma	0.000703	0.0021	CcSEcCtD
Guanabenz—Infection—Dactinomycin—melanoma	0.000699	0.00208	CcSEcCtD
Guanabenz—Leukopenia—Temozolomide—melanoma	0.000698	0.00208	CcSEcCtD
Guanabenz—Hypertension—Carmustine—melanoma	0.000696	0.00208	CcSEcCtD
Guanabenz—Thrombocytopenia—Dactinomycin—melanoma	0.000689	0.00205	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Bleomycin—melanoma	0.000687	0.00205	CcSEcCtD
Guanabenz—Chest pain—Carmustine—melanoma	0.000687	0.00205	CcSEcCtD
Guanabenz—Myalgia—Carmustine—melanoma	0.000687	0.00205	CcSEcCtD
Guanabenz—Anxiety—Carmustine—melanoma	0.000684	0.00204	CcSEcCtD
Guanabenz—Cough—Temozolomide—melanoma	0.00068	0.00203	CcSEcCtD
Guanabenz—Paraesthesia—Bleomycin—melanoma	0.000677	0.00202	CcSEcCtD
Guanabenz—Weight increased—Docetaxel—melanoma	0.000677	0.00202	CcSEcCtD
Guanabenz—Weight decreased—Docetaxel—melanoma	0.000673	0.00201	CcSEcCtD
Guanabenz—Hypertension—Temozolomide—melanoma	0.000673	0.00201	CcSEcCtD
Guanabenz—Dyspnoea—Bleomycin—melanoma	0.000672	0.002	CcSEcCtD
Guanabenz—Anorexia—Dactinomycin—melanoma	0.00067	0.002	CcSEcCtD
Guanabenz—Confusional state—Carmustine—melanoma	0.000664	0.00198	CcSEcCtD
Guanabenz—Myalgia—Temozolomide—melanoma	0.000664	0.00198	CcSEcCtD
Guanabenz—Arthralgia—Temozolomide—melanoma	0.000664	0.00198	CcSEcCtD
Guanabenz—Infestation NOS—Docetaxel—melanoma	0.000663	0.00198	CcSEcCtD
Guanabenz—Infestation—Docetaxel—melanoma	0.000663	0.00198	CcSEcCtD
Guanabenz—Anxiety—Temozolomide—melanoma	0.000661	0.00197	CcSEcCtD
Guanabenz—Oedema—Carmustine—melanoma	0.000658	0.00196	CcSEcCtD
Guanabenz—Discomfort—Temozolomide—melanoma	0.000656	0.00195	CcSEcCtD
Guanabenz—Decreased appetite—Bleomycin—melanoma	0.000656	0.00195	CcSEcCtD
Guanabenz—Infection—Carmustine—melanoma	0.000654	0.00195	CcSEcCtD
Guanabenz—Dry mouth—Temozolomide—melanoma	0.000649	0.00193	CcSEcCtD
Guanabenz—Pain—Bleomycin—melanoma	0.000645	0.00192	CcSEcCtD
Guanabenz—Thrombocytopenia—Carmustine—melanoma	0.000645	0.00192	CcSEcCtD
Guanabenz—Tachycardia—Carmustine—melanoma	0.000643	0.00192	CcSEcCtD
Guanabenz—Confusional state—Temozolomide—melanoma	0.000641	0.00191	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000641	0.00191	CcSEcCtD
Guanabenz—Oedema—Temozolomide—melanoma	0.000636	0.0019	CcSEcCtD
Guanabenz—Infection—Temozolomide—melanoma	0.000632	0.00188	CcSEcCtD
Guanabenz—Anorexia—Carmustine—melanoma	0.000628	0.00187	CcSEcCtD
Guanabenz—Nervous system disorder—Temozolomide—melanoma	0.000624	0.00186	CcSEcCtD
Guanabenz—Thrombocytopenia—Temozolomide—melanoma	0.000623	0.00186	CcSEcCtD
Guanabenz—Feeling abnormal—Bleomycin—melanoma	0.000622	0.00185	CcSEcCtD
Guanabenz—Skin disorder—Temozolomide—melanoma	0.000618	0.00184	CcSEcCtD
Guanabenz—Hypotension—Carmustine—melanoma	0.000615	0.00183	CcSEcCtD
Guanabenz—Decreased appetite—Dactinomycin—melanoma	0.000611	0.00182	CcSEcCtD
Guanabenz—Fatigue—Dactinomycin—melanoma	0.000606	0.00181	CcSEcCtD
Guanabenz—Anorexia—Temozolomide—melanoma	0.000606	0.00181	CcSEcCtD
Guanabenz—Pain—Dactinomycin—melanoma	0.000602	0.00179	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Carmustine—melanoma	0.0006	0.00179	CcSEcCtD
Guanabenz—Urticaria—Bleomycin—melanoma	0.000599	0.00179	CcSEcCtD
Guanabenz—Haemoglobin—Docetaxel—melanoma	0.000599	0.00178	CcSEcCtD
Guanabenz—Body temperature increased—Bleomycin—melanoma	0.000596	0.00178	CcSEcCtD
Guanabenz—Haemorrhage—Docetaxel—melanoma	0.000596	0.00178	CcSEcCtD
Guanabenz—Paraesthesia—Carmustine—melanoma	0.000591	0.00176	CcSEcCtD
Guanabenz—Dyspnoea—Carmustine—melanoma	0.000587	0.00175	CcSEcCtD
Guanabenz—Oedema peripheral—Docetaxel—melanoma	0.000587	0.00175	CcSEcCtD
Guanabenz—Connective tissue disorder—Docetaxel—melanoma	0.000585	0.00174	CcSEcCtD
Guanabenz—Feeling abnormal—Dactinomycin—melanoma	0.00058	0.00173	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Temozolomide—melanoma	0.00058	0.00173	CcSEcCtD
Guanabenz—Gastrointestinal pain—Dactinomycin—melanoma	0.000575	0.00171	CcSEcCtD
Guanabenz—Decreased appetite—Carmustine—melanoma	0.000572	0.00171	CcSEcCtD
Guanabenz—Paraesthesia—Temozolomide—melanoma	0.000571	0.0017	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Carmustine—melanoma	0.000568	0.00169	CcSEcCtD
Guanabenz—Dyspnoea—Temozolomide—melanoma	0.000567	0.00169	CcSEcCtD
Guanabenz—Erythema multiforme—Docetaxel—melanoma	0.000563	0.00168	CcSEcCtD
Guanabenz—Pain—Carmustine—melanoma	0.000563	0.00168	CcSEcCtD
Guanabenz—Constipation—Carmustine—melanoma	0.000563	0.00168	CcSEcCtD
Guanabenz—Dyspepsia—Temozolomide—melanoma	0.00056	0.00167	CcSEcCtD
Guanabenz—Eye disorder—Docetaxel—melanoma	0.000557	0.00166	CcSEcCtD
Guanabenz—Abdominal pain—Dactinomycin—melanoma	0.000556	0.00166	CcSEcCtD
Guanabenz—Body temperature increased—Dactinomycin—melanoma	0.000556	0.00166	CcSEcCtD
Guanabenz—Hypersensitivity—Bleomycin—melanoma	0.000556	0.00166	CcSEcCtD
Guanabenz—Decreased appetite—Temozolomide—melanoma	0.000553	0.00165	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Temozolomide—melanoma	0.000549	0.00164	CcSEcCtD
Guanabenz—Fatigue—Temozolomide—melanoma	0.000549	0.00164	CcSEcCtD
Guanabenz—Pain—Temozolomide—melanoma	0.000544	0.00162	CcSEcCtD
Guanabenz—Constipation—Temozolomide—melanoma	0.000544	0.00162	CcSEcCtD
Guanabenz—Feeling abnormal—Carmustine—melanoma	0.000543	0.00162	CcSEcCtD
Guanabenz—Asthenia—Bleomycin—melanoma	0.000541	0.00161	CcSEcCtD
Guanabenz—Gastrointestinal pain—Carmustine—melanoma	0.000538	0.0016	CcSEcCtD
Guanabenz—Immune system disorder—Docetaxel—melanoma	0.000538	0.0016	CcSEcCtD
Guanabenz—Mediastinal disorder—Docetaxel—melanoma	0.000537	0.0016	CcSEcCtD
Guanabenz—Chills—Docetaxel—melanoma	0.000534	0.00159	CcSEcCtD
Guanabenz—Pruritus—Bleomycin—melanoma	0.000534	0.00159	CcSEcCtD
Guanabenz—Feeling abnormal—Temozolomide—melanoma	0.000524	0.00156	CcSEcCtD
Guanabenz—Abdominal pain—Carmustine—melanoma	0.00052	0.00155	CcSEcCtD
Guanabenz—Body temperature increased—Carmustine—melanoma	0.00052	0.00155	CcSEcCtD
Guanabenz—Gastrointestinal pain—Temozolomide—melanoma	0.00052	0.00155	CcSEcCtD
Guanabenz—Erythema—Docetaxel—melanoma	0.000518	0.00155	CcSEcCtD
Guanabenz—Malnutrition—Docetaxel—melanoma	0.000518	0.00155	CcSEcCtD
Guanabenz—Hypersensitivity—Dactinomycin—melanoma	0.000518	0.00154	CcSEcCtD
Guanabenz—Urticaria—Temozolomide—melanoma	0.000505	0.00151	CcSEcCtD
Guanabenz—Asthenia—Dactinomycin—melanoma	0.000505	0.0015	CcSEcCtD
Guanabenz—Body temperature increased—Temozolomide—melanoma	0.000503	0.0015	CcSEcCtD
Guanabenz—Abdominal pain—Temozolomide—melanoma	0.000503	0.0015	CcSEcCtD
Guanabenz—Back pain—Docetaxel—melanoma	0.000501	0.00149	CcSEcCtD
Guanabenz—Muscle spasms—Docetaxel—melanoma	0.000498	0.00149	CcSEcCtD
Guanabenz—Hypersensitivity—Carmustine—melanoma	0.000485	0.00145	CcSEcCtD
Guanabenz—Diarrhoea—Dactinomycin—melanoma	0.000481	0.00143	CcSEcCtD
Guanabenz—Vomiting—Bleomycin—melanoma	0.00048	0.00143	CcSEcCtD
Guanabenz—Anaemia—Docetaxel—melanoma	0.000479	0.00143	CcSEcCtD
Guanabenz—Rash—Bleomycin—melanoma	0.000476	0.00142	CcSEcCtD
Guanabenz—Dermatitis—Bleomycin—melanoma	0.000475	0.00142	CcSEcCtD
Guanabenz—Asthenia—Carmustine—melanoma	0.000472	0.00141	CcSEcCtD
Guanabenz—Hypersensitivity—Temozolomide—melanoma	0.000469	0.0014	CcSEcCtD
Guanabenz—Syncope—Docetaxel—melanoma	0.000465	0.00139	CcSEcCtD
Guanabenz—Leukopenia—Docetaxel—melanoma	0.000464	0.00138	CcSEcCtD
Guanabenz—Asthenia—Temozolomide—melanoma	0.000456	0.00136	CcSEcCtD
Guanabenz—Loss of consciousness—Docetaxel—melanoma	0.000456	0.00136	CcSEcCtD
Guanabenz—Cough—Docetaxel—melanoma	0.000452	0.00135	CcSEcCtD
Guanabenz—Diarrhoea—Carmustine—melanoma	0.00045	0.00134	CcSEcCtD
Guanabenz—Pruritus—Temozolomide—melanoma	0.00045	0.00134	CcSEcCtD
Guanabenz—Nausea—Bleomycin—melanoma	0.000448	0.00134	CcSEcCtD
Guanabenz—Hypertension—Docetaxel—melanoma	0.000448	0.00133	CcSEcCtD
Guanabenz—Vomiting—Dactinomycin—melanoma	0.000447	0.00133	CcSEcCtD
Guanabenz—Rash—Dactinomycin—melanoma	0.000444	0.00132	CcSEcCtD
Guanabenz—Chest pain—Docetaxel—melanoma	0.000441	0.00132	CcSEcCtD
Guanabenz—Arthralgia—Docetaxel—melanoma	0.000441	0.00132	CcSEcCtD
Guanabenz—Myalgia—Docetaxel—melanoma	0.000441	0.00132	CcSEcCtD
Guanabenz—Dizziness—Carmustine—melanoma	0.000435	0.0013	CcSEcCtD
Guanabenz—Diarrhoea—Temozolomide—melanoma	0.000435	0.0013	CcSEcCtD
Guanabenz—Dry mouth—Docetaxel—melanoma	0.000432	0.00129	CcSEcCtD
Guanabenz—Confusional state—Docetaxel—melanoma	0.000427	0.00127	CcSEcCtD
Guanabenz—Oedema—Docetaxel—melanoma	0.000423	0.00126	CcSEcCtD
Guanabenz—Dizziness—Temozolomide—melanoma	0.000421	0.00125	CcSEcCtD
Guanabenz—Infection—Docetaxel—melanoma	0.00042	0.00125	CcSEcCtD
Guanabenz—Vomiting—Carmustine—melanoma	0.000419	0.00125	CcSEcCtD
Guanabenz—Nausea—Dactinomycin—melanoma	0.000418	0.00125	CcSEcCtD
Guanabenz—Shock—Docetaxel—melanoma	0.000416	0.00124	CcSEcCtD
Guanabenz—Rash—Carmustine—melanoma	0.000415	0.00124	CcSEcCtD
Guanabenz—Nervous system disorder—Docetaxel—melanoma	0.000415	0.00124	CcSEcCtD
Guanabenz—Dermatitis—Carmustine—melanoma	0.000415	0.00124	CcSEcCtD
Guanabenz—Thrombocytopenia—Docetaxel—melanoma	0.000414	0.00123	CcSEcCtD
Guanabenz—Tachycardia—Docetaxel—melanoma	0.000413	0.00123	CcSEcCtD
Guanabenz—Headache—Carmustine—melanoma	0.000412	0.00123	CcSEcCtD
Guanabenz—Skin disorder—Docetaxel—melanoma	0.000411	0.00123	CcSEcCtD
Guanabenz—Vomiting—Temozolomide—melanoma	0.000405	0.00121	CcSEcCtD
Guanabenz—Anorexia—Docetaxel—melanoma	0.000403	0.0012	CcSEcCtD
Guanabenz—Rash—Temozolomide—melanoma	0.000401	0.0012	CcSEcCtD
Guanabenz—Dermatitis—Temozolomide—melanoma	0.000401	0.00119	CcSEcCtD
Guanabenz—Headache—Temozolomide—melanoma	0.000399	0.00119	CcSEcCtD
Guanabenz—Hypotension—Docetaxel—melanoma	0.000395	0.00118	CcSEcCtD
Guanabenz—Nausea—Carmustine—melanoma	0.000391	0.00117	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Docetaxel—melanoma	0.000385	0.00115	CcSEcCtD
Guanabenz—Paraesthesia—Docetaxel—melanoma	0.00038	0.00113	CcSEcCtD
Guanabenz—Nausea—Temozolomide—melanoma	0.000378	0.00113	CcSEcCtD
Guanabenz—Dyspnoea—Docetaxel—melanoma	0.000377	0.00112	CcSEcCtD
Guanabenz—Dyspepsia—Docetaxel—melanoma	0.000372	0.00111	CcSEcCtD
Guanabenz—Decreased appetite—Docetaxel—melanoma	0.000368	0.0011	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Docetaxel—melanoma	0.000365	0.00109	CcSEcCtD
Guanabenz—Fatigue—Docetaxel—melanoma	0.000365	0.00109	CcSEcCtD
Guanabenz—Constipation—Docetaxel—melanoma	0.000362	0.00108	CcSEcCtD
Guanabenz—Pain—Docetaxel—melanoma	0.000362	0.00108	CcSEcCtD
Guanabenz—Feeling abnormal—Docetaxel—melanoma	0.000349	0.00104	CcSEcCtD
Guanabenz—Gastrointestinal pain—Docetaxel—melanoma	0.000346	0.00103	CcSEcCtD
Guanabenz—Abdominal pain—Docetaxel—melanoma	0.000334	0.000997	CcSEcCtD
Guanabenz—Body temperature increased—Docetaxel—melanoma	0.000334	0.000997	CcSEcCtD
Guanabenz—Hypersensitivity—Docetaxel—melanoma	0.000312	0.000929	CcSEcCtD
Guanabenz—Asthenia—Docetaxel—melanoma	0.000304	0.000905	CcSEcCtD
Guanabenz—Pruritus—Docetaxel—melanoma	0.000299	0.000892	CcSEcCtD
Guanabenz—Diarrhoea—Docetaxel—melanoma	0.000289	0.000863	CcSEcCtD
Guanabenz—Dizziness—Docetaxel—melanoma	0.00028	0.000834	CcSEcCtD
Guanabenz—Vomiting—Docetaxel—melanoma	0.000269	0.000802	CcSEcCtD
Guanabenz—Rash—Docetaxel—melanoma	0.000267	0.000795	CcSEcCtD
Guanabenz—Dermatitis—Docetaxel—melanoma	0.000267	0.000794	CcSEcCtD
Guanabenz—Headache—Docetaxel—melanoma	0.000265	0.00079	CcSEcCtD
Guanabenz—Nausea—Docetaxel—melanoma	0.000251	0.000749	CcSEcCtD
Guanabenz—ADRA2A—Signaling Pathways—AKT3—melanoma	2.64e-05	0.000175	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—IL2—melanoma	2.63e-05	0.000174	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—E2F1—melanoma	2.61e-05	0.000173	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—PIK3CB—melanoma	2.6e-05	0.000172	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—MAPK1—melanoma	2.58e-05	0.000172	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PDGFRA—melanoma	2.58e-05	0.000171	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—ITGB3—melanoma	2.56e-05	0.00017	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PRKCA—melanoma	2.56e-05	0.00017	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—IL2—melanoma	2.56e-05	0.00017	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—HRAS—melanoma	2.55e-05	0.00017	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—VCAN—melanoma	2.55e-05	0.000169	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—TERT—melanoma	2.55e-05	0.000169	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—RAC1—melanoma	2.54e-05	0.000168	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—SPP1—melanoma	2.51e-05	0.000166	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MAP2K2—melanoma	2.5e-05	0.000166	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—CXCL8—melanoma	2.5e-05	0.000166	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PRKCA—melanoma	2.49e-05	0.000165	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—ERCC2—melanoma	2.46e-05	0.000164	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—SOCS1—melanoma	2.44e-05	0.000162	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—KRAS—melanoma	2.44e-05	0.000162	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—MAP2K1—melanoma	2.44e-05	0.000162	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—S100B—melanoma	2.44e-05	0.000162	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—HIF1A—melanoma	2.44e-05	0.000162	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—PIK3CD—melanoma	2.42e-05	0.000161	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—AKT1—melanoma	2.41e-05	0.00016	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.41e-05	0.00016	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PIK3CG—melanoma	2.4e-05	0.000159	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—IL2—melanoma	2.39e-05	0.000158	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—TERT—melanoma	2.38e-05	0.000158	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—RAC1—melanoma	2.37e-05	0.000157	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—ERBB4—melanoma	2.33e-05	0.000155	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—KDR—melanoma	2.33e-05	0.000155	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.33e-05	0.000155	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—PIK3CB—melanoma	2.33e-05	0.000154	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PPARG—melanoma	2.31e-05	0.000153	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CDKN2B—melanoma	2.31e-05	0.000153	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—HIF1A—melanoma	2.27e-05	0.000151	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—AKT1—melanoma	2.26e-05	0.00015	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—PIK3CA—melanoma	2.24e-05	0.000149	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—FN1—melanoma	2.24e-05	0.000149	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CD86—melanoma	2.24e-05	0.000148	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—CXCL8—melanoma	2.23e-05	0.000148	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—EDN1—melanoma	2.22e-05	0.000147	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—NOTCH1—melanoma	2.19e-05	0.000146	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—KDR—melanoma	2.18e-05	0.000144	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—TP53—melanoma	2.17e-05	0.000144	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CSF2—melanoma	2.17e-05	0.000144	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—FGF1—melanoma	2.17e-05	0.000144	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CYP17A1—melanoma	2.15e-05	0.000143	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CD80—melanoma	2.15e-05	0.000143	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—APC—melanoma	2.15e-05	0.000142	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PIK3CG—melanoma	2.15e-05	0.000142	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—KIT—melanoma	2.15e-05	0.000142	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—NRAS—melanoma	2.15e-05	0.000142	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—IL2—melanoma	2.14e-05	0.000142	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.12e-05	0.000141	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—E2F1—melanoma	2.12e-05	0.000141	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—EGF—melanoma	2.12e-05	0.000141	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—PIK3CB—melanoma	2.11e-05	0.00014	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PIK3CD—melanoma	2.11e-05	0.00014	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PDGFRA—melanoma	2.1e-05	0.000139	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—FN1—melanoma	2.09e-05	0.000139	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	2.09e-05	0.000139	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—ALB—melanoma	2.08e-05	0.000138	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—ITGB3—melanoma	2.08e-05	0.000138	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PRKCA—melanoma	2.08e-05	0.000138	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—HRAS—melanoma	2.07e-05	0.000138	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—MAPK3—melanoma	2.05e-05	0.000136	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—NOTCH1—melanoma	2.05e-05	0.000136	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—SPP1—melanoma	2.04e-05	0.000135	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MAP2K2—melanoma	2.03e-05	0.000135	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GNA11—melanoma	2.03e-05	0.000135	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—CXCL8—melanoma	2.03e-05	0.000135	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—BRAF—melanoma	2.02e-05	0.000134	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CD80—melanoma	2.01e-05	0.000133	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—KIT—melanoma	2e-05	0.000133	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PIK3CG—melanoma	2e-05	0.000133	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—APC—melanoma	2e-05	0.000133	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—NRAS—melanoma	2e-05	0.000133	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—FASN—melanoma	1.99e-05	0.000132	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—EGF—melanoma	1.98e-05	0.000131	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IGF1—melanoma	1.96e-05	0.00013	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—SLC5A5—melanoma	1.96e-05	0.00013	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—MAPK1—melanoma	1.95e-05	0.00013	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—EGFR—melanoma	1.95e-05	0.00013	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PIK3CG—melanoma	1.95e-05	0.000129	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—IL2—melanoma	1.94e-05	0.000129	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—TERT—melanoma	1.93e-05	0.000128	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—RAC1—melanoma	1.93e-05	0.000128	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—MAPK3—melanoma	1.92e-05	0.000127	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MAP2K1—melanoma	1.9e-05	0.000126	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CD44—melanoma	1.89e-05	0.000125	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GNAQ—melanoma	1.89e-05	0.000125	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PIK3CD—melanoma	1.89e-05	0.000125	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—BRAF—melanoma	1.88e-05	0.000125	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PPARG—melanoma	1.88e-05	0.000125	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—PIK3CA—melanoma	1.87e-05	0.000124	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.85e-05	0.000123	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—HIF1A—melanoma	1.85e-05	0.000123	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—KRAS—melanoma	1.85e-05	0.000123	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PIK3CB—melanoma	1.84e-05	0.000122	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IGF1—melanoma	1.83e-05	0.000122	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—AKT1—melanoma	1.83e-05	0.000122	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.83e-05	0.000122	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—MAPK1—melanoma	1.83e-05	0.000121	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—EGFR—melanoma	1.83e-05	0.000121	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PTGS2—melanoma	1.82e-05	0.000121	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CYP1B1—melanoma	1.81e-05	0.00012	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—FGF2—melanoma	1.81e-05	0.00012	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MAP2K1—melanoma	1.77e-05	0.000118	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—KDR—melanoma	1.77e-05	0.000117	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PIK3CD—melanoma	1.76e-05	0.000117	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—PIK3CA—melanoma	1.74e-05	0.000116	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—KRAS—melanoma	1.72e-05	0.000114	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PIK3CD—melanoma	1.71e-05	0.000114	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—FN1—melanoma	1.7e-05	0.000113	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—PIK3CA—melanoma	1.7e-05	0.000113	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MDM2—melanoma	1.69e-05	0.000112	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—ALB—melanoma	1.69e-05	0.000112	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—FGF2—melanoma	1.69e-05	0.000112	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—ERBB2—melanoma	1.67e-05	0.000111	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—NOTCH1—melanoma	1.66e-05	0.00011	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PIK3CB—melanoma	1.64e-05	0.000109	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CD80—melanoma	1.63e-05	0.000108	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PIK3CG—melanoma	1.63e-05	0.000108	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—APC—melanoma	1.63e-05	0.000108	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—KIT—melanoma	1.63e-05	0.000108	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—NRAS—melanoma	1.63e-05	0.000108	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—EGF—melanoma	1.61e-05	0.000107	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.6e-05	0.000106	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PTEN—melanoma	1.59e-05	0.000105	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—PIK3CA—melanoma	1.58e-05	0.000105	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CXCL8—melanoma	1.58e-05	0.000105	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MDM2—melanoma	1.58e-05	0.000105	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—HRAS—melanoma	1.57e-05	0.000104	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—MAPK3—melanoma	1.56e-05	0.000103	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—ERBB2—melanoma	1.56e-05	0.000103	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CDKN1B—melanoma	1.54e-05	0.000102	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PIK3CB—melanoma	1.54e-05	0.000102	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—BRAF—melanoma	1.53e-05	0.000102	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—AKT1—melanoma	1.53e-05	0.000101	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CASP3—melanoma	1.51e-05	0.0001	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IL2—melanoma	1.51e-05	0.0001	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—IL6—melanoma	1.5e-05	9.97e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PIK3CB—melanoma	1.49e-05	9.9e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ABCB1—melanoma	1.49e-05	9.89e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IGF1—melanoma	1.49e-05	9.89e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—MAPK1—melanoma	1.48e-05	9.84e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—EGFR—melanoma	1.48e-05	9.84e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PTGS2—melanoma	1.48e-05	9.81e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CXCL8—melanoma	1.48e-05	9.79e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CCND1—melanoma	1.47e-05	9.77e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—HRAS—melanoma	1.47e-05	9.73e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CTNNB1—melanoma	1.46e-05	9.67e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CDKN1B—melanoma	1.44e-05	9.56e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MAP2K1—melanoma	1.44e-05	9.56e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PIK3CD—melanoma	1.43e-05	9.5e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MMP9—melanoma	1.43e-05	9.48e-05	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—AKT1—melanoma	1.43e-05	9.46e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CDKN1A—melanoma	1.42e-05	9.45e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PTEN—melanoma	1.42e-05	9.43e-05	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—PIK3CA—melanoma	1.42e-05	9.4e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—NFKB1—melanoma	1.41e-05	9.38e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CASP3—melanoma	1.41e-05	9.37e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IL2—melanoma	1.41e-05	9.36e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—IL6—melanoma	1.4e-05	9.31e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—KRAS—melanoma	1.4e-05	9.3e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—AKT1—melanoma	1.39e-05	9.2e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CCND1—melanoma	1.37e-05	9.12e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PRKCA—melanoma	1.37e-05	9.1e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—FGF2—melanoma	1.37e-05	9.09e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CTNNB1—melanoma	1.36e-05	9.03e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ERCC2—melanoma	1.36e-05	9.03e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MMP9—melanoma	1.33e-05	8.86e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CDKN1A—melanoma	1.33e-05	8.82e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PTEN—melanoma	1.33e-05	8.8e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—NFKB1—melanoma	1.32e-05	8.76e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—AKT1—melanoma	1.29e-05	8.59e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PTEN—melanoma	1.29e-05	8.55e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—PIK3CA—melanoma	1.29e-05	8.54e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—VEGFA—melanoma	1.28e-05	8.51e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MDM2—melanoma	1.28e-05	8.51e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—STAT3—melanoma	1.27e-05	8.43e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—NRAS—melanoma	1.27e-05	8.41e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—ERBB2—melanoma	1.26e-05	8.39e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PIK3CB—melanoma	1.25e-05	8.28e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MAPK3—melanoma	1.21e-05	8.05e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CXCL8—melanoma	1.2e-05	7.95e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—VEGFA—melanoma	1.2e-05	7.95e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—HRAS—melanoma	1.19e-05	7.9e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—STAT3—melanoma	1.19e-05	7.87e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—NRAS—melanoma	1.18e-05	7.86e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MYC—melanoma	1.18e-05	7.83e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CDKN1B—melanoma	1.17e-05	7.77e-05	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—AKT1—melanoma	1.16e-05	7.68e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MAPK1—melanoma	1.15e-05	7.66e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—EGFR—melanoma	1.15e-05	7.66e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CASP3—melanoma	1.15e-05	7.61e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IL2—melanoma	1.15e-05	7.6e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—IL6—melanoma	1.14e-05	7.56e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MAPK3—melanoma	1.13e-05	7.52e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.13e-05	7.48e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PIK3CA—melanoma	1.12e-05	7.43e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CCND1—melanoma	1.12e-05	7.41e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CTNNB1—melanoma	1.11e-05	7.34e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MYC—melanoma	1.1e-05	7.32e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—KRAS—melanoma	1.09e-05	7.24e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MMP9—melanoma	1.08e-05	7.19e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CDKN1A—melanoma	1.08e-05	7.17e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MAPK1—melanoma	1.08e-05	7.16e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—EGFR—melanoma	1.08e-05	7.16e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PTEN—melanoma	1.08e-05	7.15e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PIK3CG—melanoma	1.07e-05	7.13e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—NFKB1—melanoma	1.07e-05	7.12e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—AKT1—melanoma	1.05e-05	6.98e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PPARG—melanoma	1.04e-05	6.88e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—KRAS—melanoma	1.02e-05	6.76e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PIK3CA—melanoma	1e-05	6.65e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—VEGFA—melanoma	9.73e-06	6.46e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—TP53—melanoma	9.69e-06	6.43e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—STAT3—melanoma	9.64e-06	6.4e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—NRAS—melanoma	9.62e-06	6.38e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PIK3CD—melanoma	9.45e-06	6.27e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PIK3CA—melanoma	9.36e-06	6.21e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ALB—melanoma	9.33e-06	6.19e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—HRAS—melanoma	9.27e-06	6.15e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MAPK3—melanoma	9.21e-06	6.11e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—AKT1—melanoma	9.15e-06	6.07e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PIK3CA—melanoma	9.09e-06	6.03e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—TP53—melanoma	9.06e-06	6.01e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MYC—melanoma	8.96e-06	5.94e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IL6—melanoma	8.87e-06	5.89e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MAPK1—melanoma	8.76e-06	5.81e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—EGFR—melanoma	8.76e-06	5.81e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—HRAS—melanoma	8.66e-06	5.75e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IL6—melanoma	8.29e-06	5.5e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—KRAS—melanoma	8.28e-06	5.49e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PIK3CB—melanoma	8.23e-06	5.46e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—AKT1—melanoma	8.19e-06	5.43e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PTGS2—melanoma	8.16e-06	5.41e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—AKT1—melanoma	7.65e-06	5.07e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PIK3CA—melanoma	7.6e-06	5.05e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—AKT1—melanoma	7.43e-06	4.93e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—TP53—melanoma	7.36e-06	4.88e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PTEN—melanoma	7.12e-06	4.72e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—HRAS—melanoma	7.03e-06	4.67e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IL6—melanoma	6.73e-06	4.47e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—AKT1—melanoma	6.21e-06	4.12e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PIK3CA—melanoma	5.02e-06	3.33e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—AKT1—melanoma	4.1e-06	2.72e-05	CbGpPWpGaD
